Back to Journals » Cancer Management and Research » Volume 11

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

Total article views   HTML views PDF downloads Totals
5,868 Dovepress* 5,357+ 761 6,118
PubMed Central* 511 182 693
Totals 5,868 943 6,811
*Since 12 December 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar